← Eichor
Study identifier: NCT06860867 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PerQdisc Traditional Feasibility Trial.

Condition: Discogenic Low Back Pain  ·  Sponsor: Spinal Stabilization Technologies

PhaseNA
Planned participants5
Who can joinAll sexes, 22 Years to 70 Years
Healthy volunteersNo

About this study

This is a traditional feasibility study (TFS) study to evaluate the safety and effectiveness of the PerQdisc. The study is prospective, multicenter, and open label. After a screening period, qualified participants will be enrolled and treated with the PerQdisc. Patients will not be blinded to their treatment. Participants will then complete the safety follow-up period.

This description comes directly from the study's public registry record.

Talk to the study team

Molly Bond  ·  1-800-484-1588  ·  clinical@sstspine.com

Always discuss trial participation with your own doctor first.

Locations (8)

Hope Research InstituteGlendale, Arizona, United StatesWithdrawn
The CORE InstitutePhoenix, Arizona, United StatesRecruiting
HOPE Research InstitutePhoenix, Arizona, United StatesWithdrawn
HonorHealth Research & Innovation InstituteScottsdale, Arizona, United StatesRecruiting
Axis Spine CenterCoeur d'Alene, Idaho, United StatesRecruiting
Indiana Spine GroupCarmel, Indiana, United StatesRecruiting
Spine Institute of LouisianaShreveport, Louisiana, United StatesRecruiting
SonoSpineOklahoma City, Oklahoma, United StatesWithdrawn

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06860867